2025-05-29 - Analysis Report
Okay, here's an analysis of TG Therapeutics Inc (TGTX) based on the provided data, presented as a concise report.

## TGTX Stock Analysis

**Ticker:** TGTX (TG Therapeutics Inc)

**Company Overview:**  TG Therapeutics Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance vs. S&P 500 (VOO)

*   **TGTX Cumulative Return:** 65.98%
*   **VOO Cumulative Return:** 82.09%
*   **Absolute Divergence:** -16.1% (TGTX underperformed VOO by 16.1% at the end of the period)
*   **Relative Divergence:** 19.5 (This indicates that the current divergence is near the lower end of its historical range relative to VOO. In other words, the underperformance is relatively less severe compared to some periods in the past.)
*   **Divergence Range:** Min: -115.8, Max: 395.2

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta   | Cap(B) |
| :----------- | :------ | :------ | :----- | :----- | :----- |
| 2015-2017  | -6.0%   | 56.5% | -35.0% | -0.1   | 1.3    |
| 2016-2018  | -8.0%   | 58.6% | -26.0% | -0.0   | 0.7    |
| 2017-2019  | 74.0%   | 58.6% | 44.0%  | -0.0   | 1.8    |
| 2018-2020  | 402.0%  | 58.6% | 377.0% | -0.1   | 8.3    |
| 2019-2021  | 125.0%  | 63.5% | 70.0%  | -0.2   | 3.0    |
| 2020-2022  | -76.0%  | 70.4% | -82.0% | -0.3   | 1.9    |
| 2021-2023  | -350.0% | 70.4% | -367.0% | -0.8   | 2.7    |
| 2022-2024  | 71.0%   | 73.1% | 54.0%  | -1.0   | 4.8    |
| 2023-2025  | 73.0%   | 73.1% | 43.0%  | 0.3    | 5.6    |

*   **Analysis:**  TGTX has shown significant volatility and periods of both strong outperformance and underperformance relative to the S&P 500. The negative Alpha values in many periods indicate underperformance on a risk-adjusted basis. The Beta values are generally low, suggesting a low correlation to the market.

### 2. Recent Stock Price Movements

*   **Current Price:** $35.14
*   **Previous Close:** $35.24
*   **Price Change:** -0.28
*   **5-day Moving Average:** $34.678
*   **20-day Moving Average:** $36.138
*   **60-day Moving Average:** $38.0755

*   **Analysis:** The stock price is currently below both its 20-day and 60-day moving averages, suggesting a recent downtrend. The 5-day moving average is below the current price, potentially indicating a very short-term upward movement. The price decrease is not significant, so not a major volatility event.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 51.67 (Neutral)
*   **PPO:** 0.1305 (Neutral)
*   **Hybrid Signal:** Cash_16%_Buy 80% of cash (3791 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Divergence Change:** +0.1 (Short-term increase)
*   **Expected Return (%):** -202.0 (Long-term underperformance vs. S&P 500)

*   **Analysis:** The Market Risk Indicator suggests low risk. The RSI is neutral, indicating neither overbought nor oversold conditions. The PPO is also relatively neutral. The hybrid signal suggests a buy with caution. The increased (20-day) Relative Divergence Change suggests a short-term increase compared to S&P 500. However, the very negative expected return suggests significant long-term concerns relative to the S&P 500.

### 4. Recent News & Events

*   **Summary:**  Recent news indicates TGTX has been subject to major business developments, regulatory changes, or market events.  Analysts are discussing the company's performance in the context of industry and global economic trends.  The stock has shown volatility, and experts advise monitoring news and announcements.

*   **Analysis:** The news suggests that TGTX is experiencing significant activity, which could be driving both opportunities and risks.  Investors should closely monitor developments.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출       |
| :----------- | :---- | :--------- |
| 2025-05-09 | 0.03  | 0.12 B$    |
| 2024-11-07 | 0.03  | 0.08 B$    |
| 2024-08-09 | 0.05  | 0.07 B$    |
| 2024-05-06 | -0.07 | 0.06 B$    |
| 2025-05-09 | -0.07 | 0.06 B$    |

*   **Analysis:** The recent earnings data shows a mixed picture. TGTX has recently reported positive EPS, showing improving profitability. Revenue has generally been increasing.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
| :----------- | :------- | :------------ |
| 2025-03-31 | $0.12B | 87.14%        |
| 2024-12-31 | $0.11B | 85.77%        |
| 2024-09-30 | $0.08B | 88.86%        |
| 2024-06-30 | $0.07B | 88.70%        |
| 2024-03-31 | $0.06B | 91.43%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
| :----------- | :------- | :------- |
| 2025-03-31 | $0.24B | 2.13%  |
| 2024-12-31 | $0.22B | 10.49% |
| 2024-09-30 | $0.19B | 2.02%  |
| 2024-06-30 | $0.18B | 3.87%  |
| 2024-03-31 | $0.16B | -6.69% |

*   **Analysis:** Revenue has been consistently increasing over the past year. The profit margins are very high and stable. Equity has also been increasing.  ROE has fluctuated, but is generally positive, indicating improving profitability.

### 7. Overall Summary

TGTX presents a mixed picture. Recent earnings and revenue trends are positive. Profit margins are very high, indicating efficient operations. However, the company has shown high volatility and has underperformed the S&P 500 over longer periods. The significant long-term underperformance expectations and the news of recent business developments and market volatility suggest increased uncertainty. Investors should carefully weigh the potential for growth against the risks associated with the stock.

**Recommendation:** Given the conflicting signals, a neutral or cautious stance is warranted. Further research and monitoring of upcoming news and earnings reports are recommended before making any investment decisions.
